2023-09-09 07:20:00 ET
On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S&P 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities to get in on solid value stocks that are underpriced and offer solid dividends.
Viatris (NASDAQ: VTRS) , GSK (NYSE: GSK) , and Organon (NYSE: OGN) are too inexpensive to pass up at this point. All three pharmaceutical stocks trade at under 7 times earnings and have forward price-to-earnings ratios of less than 10.
GSK PE Ratio data by YCharts.
For further details see:
3 Pharmaceutical Stocks That Are Too Cheap to Ignore